Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Dupixent COPD delay possible, Eylea down 2%, Regeneron says
The FDA has requested more efficacy data for Sanofi and Regeneron's Dupixent in COPD. Additionally, Eylea sales fell by 2% in the first quarter.
Kevin Dunleavy
May 2, 2024 12:00pm
Novo Nordisk scales Wegovy supply amid pressure from Lilly
May 2, 2024 11:56am
Sponsored
ADVI Experts Discuss the Future of the Inflation Reduction Act
Apr 29, 2024 8:00am
Moderna plots launch of its next potential mRNA vaccine approval
May 2, 2024 11:08am
Sponsored
Collaborative partnerships key to clearing the path for new biopharma products
Apr 29, 2024 8:00am
AZ clinches early Calquence win in untreated MCL
May 2, 2024 10:24am